Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Public Health,Children,Obesity And Malnutrition
From the Center
AllSides Media Bias Rating: Center
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
_2.webp)
AllSides Picks
_2.webp)
Headline Roundup
California Faces Additional $1.2 Billion Medicaid Funding Freeze Amid Fraud Allegations
October 21st, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Bias
Media Bias Alert: Are OB-GYNs Fleeing Idaho Because of Abortion Bans?
Emily Allen
October 23rd, 2026
